The global prevalence of diabetes is to rise from 171 million in 2000 to 366 million in 2030
India faces a grave health care burden due to high prevalence of Type-2 diabetes with its micro & Macrovascular complications.
As impaired glucose control is forerunner of diabetes it is essential to prevent high morbidity & mortality associated with diabetes by tight glycemic control with anti-hyperglycemic drugs.
Aspida Pharma Pvt Ltd has emerged to become the premier pharmaceutical Distributor in all over india by virtue of its excellent distribution network in the city and by its spearheading the Distribution movement of quite a few leading Indian and Multinational Pharmaceutical companies.
©2018 Aspida Pharma Pvt Ltd. All Rights Reserved | Design by SHOPWEB
Over view
Over view